Literature DB >> 11860985

Scanning laser ophthalmoscope findings in acute macular neuroretinopathy.

Arnd Gandorfer1, Michael W Ulbig.   

Abstract

PURPOSE: The typical reddish-brown retinal lesions of acute macular neuroretinopathy are difficult to detect. We demonstrate a role for scanning laser ophthalmoscopy in the diagnosis of acute macular neuroretinopathy.
METHODS: Observational case report. We used scanning laser ophthalmoscopy in a 23-year-old woman with acute macular neuroretinopathy.
RESULTS: In contrast to biomicroscopy, color fundus photography, and red-free fundus photography, scanning laser ophthalmoscopy precisely disclosed the size of the lesions within the macula. Microperimetry showed absolute scotomata corresponding to the macular lesions.
CONCLUSION: Scanning laser ophthalmoscopy enhances the visibility of the retinal lesions in acute macular neuroretinopathy. The lesion size can be determined more precisely, and follow-up of patients is more accurate compared with conventional techniques.

Entities:  

Mesh:

Year:  2002        PMID: 11860985     DOI: 10.1016/s0002-9394(01)01335-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Functional and high-resolution retinal imaging monitoring photoreceptor damage in acute macular neuroretinopathy.

Authors:  Isabelle Audo; Kiyoko Gocho; Florence Rossant; Saddek Mohand-Saïd; Kevin Loquin; Isabelle Bloch; José-Alain Sahel; Michel Paques
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-07       Impact factor: 3.117

2.  Visualization and follow-up of acute macular neuroretinopathy with the Spectralis HRA+OCT device.

Authors:  Irmingard M Neuhann; Werner Inhoffen; Sabine Koerner; Karl Ulrich Bartz-Schmidt; Faik Gelisken
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-03-03       Impact factor: 3.117

3.  Enhanced visualization of acute macular neuroretinopathy by infrared imaging and spectral optical coherence tomography.

Authors:  Emin Özmert; Rengin Aslıhan Kurt; Figen Batioğlu
Journal:  Indian J Ophthalmol       Date:  2013-12       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.